Our study found lower GIMAP1-GIMAP5 expression in malignant nodules and linked it to shorter survival in lung adenocarcinoma patients, indicating its clinical importance for diagnosis and prognosis in this disease. This evidence concerns the gene GIMAP5 and lung adenocarcinoma.